The prevalence of smoking and its impact on disability in multiple sclerosis
Abstract
Introduction: Etiology of multiple sclerosis (MS) involves multifactorial interactions among genetic and environmental factors. Cigarette smoking is one of the most important environmental factors that increase the disease risk by about 50%. The aim of the research to assess the prevalence of smoking in MS patients compared to the general population, and to assess the association between smoking and physical disability in MS patients.
Materials and Methods: A cross-sectional study included 100 MS patients and 50 healthy people. For estimation of the degree of physical disability, the Expanded Disability Status Scale (EDSS) was used, and for clinical and demographic data we used a general questionnaire. In order to collect data on the smoking, the questionnaire for examining risk factors for vascular disease among patients with MS was used.
Results: Analysis of smoking incidence showed that, between MS and control group, smoking had been a dependent variable (χ2 = 6.258, p = 0.04). In smokers, seen in both groups, there was no statistically significant difference in the number of cigarettes, nor in the duration of smoking. There was no significant correlation between smoking in MS group and the index of disease progression (r=0.216, p=0.133). Also, the relationship between EDSS and smoking had no statistical significance, as well as between the disease course and smoking (χ2 = 1.531, p = 0.216).
Conclusion: In view of the relevance of smoking in MS, it is important to modify this environmental factor and thus prevent its effect on the onset and progression of MS.
Keywords: multiple sclerosis, smoking
References
Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H. McAlpine’s multiple sclerosis. 3rd ed. London: Churchill Livingstone, 1998.
Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359: 1221–31.
Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017; 13(1):25-36.
Hedström AK. Smoking and its interaction with genetics in MS etiology. Mult Scler. 2019; 1352458518801727. doi: 10.1177/1352458518801727.
Antonovsky A, Leibovitz U, Smith HA, et al. Epidemiologic study of multiple sclerosis in Israel. I. An overall reviev of methods and findings. Arch Neurol 1965; 13: 183-193.
Hernan MA, Olek MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001; 154: 69–74.
Hernan MA, Jick SS, Logroscino G, et al. Cigarette smoking and the progression of multiple sclerosis. Brain 2005; 128: 1461–1465.
Sundstrom P, Nystrom L, Hallmans G. Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 2008; 15: 579–583.
Carlens C, Hergens MP, Grunewald J, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010; 181(11): 1217-22.
Hedström AK, Bäärnhielm M, Olsson T, et al. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis. Neurology 2009; 73(9): 696-701.
Salzer J, Stenlund H, Sundström P. The interaction between smoking and Epstein-Barr virus as multiple sclerosis risk factors may depend on age. Mult Scler 2014; 20(6): 747-50.
Hedström AK, Ryner M, Fink K, et al. Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a. Mult Scler 2014; 20(4): 445-50.
Petersen ER, Søndergaard HB, Laursen JH, et al. Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis. Mult Scler. 2018; 2:1352458518791753. doi: 10.1177/1352458518791753.
Auer M, Bsteh G, Hegen H, et al. Smoking is not associated with higher prevalence of JC virus in MS patients. Eur J Clin Microbiol Infect Dis. 2018 ;37(5):907-910. doi: 10.1007/s10096-018-3204-z.
Kurtzke JF. Rating neurologic instrument in multiple sclerosis: An expandede disability status scale (EDSS). Neurology 1983; 33: 1444-52.
Lalmohamed A, Bazelier MT, Van Staa TP, et al. Causes of death in patients with multiple sclerosis and matched referent subjects: A population-based cohort study. Eur J Neurol 2012; 19: 1007–1014.
Khurana SR, Bamer AM, Turner AP, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil 2009; 88(2): 83-91.
Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. A case-control study of the association between socio-demographic, lifestyle and medicalhistory factors and multiple sclerosis. Can J Public Health 2001; 92:281–5.
Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 2007; 13: 610–5.
Pekmezovic T, Drulovic J, Milenkovic M, et al. Lifestyle factors and multiple sclerosis: A case-control study in Belgrade. Neuroepidemiology 2006; 27(4): 212-6.
Hedström AK. Smoking is an important risk factor for MS that overall increases the risk of the disease with approximately 50%. Mult Scler. 2018 ;1352458518801727. doi: 10.1177/1352458518801727.
Hedström AK, Bäärnhielm M, Olsson T, et al. Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler 2011; 17(7): 788-93.
Salzer J, Hallmans G, Nyström M, et al. Smoking as a risk factor for multiple sclerosis. Mult Scler 2013; 19 (8): 1022-7.
Montgomery SM, Bahmanyar S, Hillert J, et al. Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol. 2008 ;15(12): 1395-9.
Mikaeloff Y, Caridade G, Tardieu M, Suissa S.
Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain 2007; 130 (10): 2589-95.
Tardieu M, Mikaeloff Y. Multiple sclerosis in children: environmental risk factors. Bull Acad Natl Med 2008; 192(3): 507-9.
Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82:4196–4200.
Munger K, Levin L, Hollis B, Howard N, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832–2838.
Thacker E, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 2006; 59: 499–503.
Asadollahi S, Fakhri M, Heidari K, Zandieh A, Vafaee R, Mansouri B. Cigarette smoking and associated risk of multiple sclerosis in the Iranian population. J Clin Neurosci 2013; 20(12): 1747-50.
Sundstrom P, Nystrom L. Smoking worsens the prognosis in multiple sclerosis. Mult Scler 2008; 14: 1031-1035.
Di Pauli F, Reindl M, Ehling R, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008; 14: 1026-1030.
Sena A, Couderc R, Ferret-Sena V, et al. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis. Eur J Neurol 2009; 16: 832-837.
Pittas F, Ponsonby AL, van der Mei IA, et al. Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis. J Neurol 2009; 256: 577-585.
Healy BC, Ali EN, Guttmann CRG, et al. Smoking and disease progression in multiple sclerosis. Arch Neurol 2009; 66: 858-864.
Zivadinov R, Weinstock-Guttman B, Hashmi K, et al. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis. Neurology 2009; 73: 504-510.
Weiland TJ, Hadgkiss EJ, Jelinek GA, Pereira NG, Marck CH, van der Meer DM. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014; 15: 336(1-2): 211-9.
Manouchehrinia A, Tench CR, Maxted J, Bibani RH, Britton J, Constantinescu CS. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study. Brain 2013; 136(7): 2298-2304.
D'hooghe MB, Haentjens P, Nagels G, De Keyser J. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis. Eur J Neurol 2012; 19(4): 616-24.
Marie RA, Horwitz RI, Cutter G, et al. Smokers with multiple sclerosisare more likely to report comorbid autoimmune diseaes. Neuroepidemiology 2011; 36: 85-90.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).